The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksQinetiq Regulatory News (QQ.)

Share Price Information for Qinetiq (QQ.)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 353.80
Bid: 353.60
Ask: 354.40
Change: 5.80 (1.67%)
Spread: 0.80 (0.226%)
Open: 350.20
High: 356.00
Low: 348.80
Prev. Close: 348.00
QQ. Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

5 Jan 2022 17:05

RNS Number : 5617X
QinetiQ Group plc
05 January 2022
 

 

QinetiQ Group plc (the "Company")

On 2 July 2021 the Company announced that Caroline (Carol) Borg, Chief Financial Officer, would receive shares with a value of £500,000 upon her appointment.

 

The Company today announces that on 5 January 2022 Caroline (Carol) Borg was granted 193,199 Ordinary shares of one pence each in the Company (the 'Award') with a value of £500,000.

 

The Award was granted under the terms of the Compensation Share Plan and the Ordinary Shares will vest on the third anniversary of grant subject to continued employment.

 

No consideration was paid for the grant of this award and no payment is due on the release of any shares.

 

The QinetiQ share price used to calculate the number of shares subject to the Award is £2.588 being the average closing price over the 30 day period prior to the award (aligned with the Remuneration Committee's standard approach).

 

The Award is being granted by the Company without prior shareholder approval in general meeting upon reliance of Listing Rule 9.4.2(2) to implement terms agreed to facilitate the participant's recruitment.

 

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities or persons closely associated with them

1.

Details of PDMR / person closely associated with them ("PCA")

(a)

Name

Caroline Borg

2.

Reason for the notification

(a)

Position / status

Chief Financial Officer/Director

(b)

Initial notification / amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

(a)

Name

QinetiQ Group plc

(b)

Legal Entity Identifier Code

213800S8OBDOZMCMUW34

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

(a)

 

Description of the financial instrument

 

Identification code

 

 

 

QinetiQ Group plc ordinary shares of 1 pence

 

 

GB00B0WMWD03

(b)

Nature of the transaction

Award of Shares under the Compensation Share Plan

(c)

Price(s) and volume(s)

Price(s)

Volume(s)

£2.588

193,199

 

(d)

 

Aggregated information

 

- Price

 

- Volume

 

- Total

 

 

 

 

£2.588 per share

 

193,199

 

£499,999.012

 

(e)

Date of the transaction

2022-01-05

(f)

Place of the transaction

Outside of a Trading Venue

 

 

 

Enquiries:

Company Secretary:

Jon Messent, QinetiQ

+44 (0)1252 392000

Investor Relations:

John Haworth, QinetiQ

+44 (0) 7920 545841

Media Relations:

QinetiQ Press Office

+44 (0)1252 393500

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHSSEFWIEESESF
Date   Source Headline
30th Mar 20237:00 amRNSQinetiQ Awarded $92.6M Contract
23rd Mar 20235:00 pmRNSDirectorate Change
20th Mar 202310:30 amRNSDirector Declaration
15th Mar 20232:40 pmRNSDirector Declaration
10th Mar 20232:56 pmRNSDirector/PDMR Shareholding
17th Feb 20239:00 amRNSHolding(s) in Company
16th Feb 20237:00 amRNSGary Stewart appointed CEO for Australia Sector
10th Feb 20231:14 pmRNSDirector/PDMR Shareholding
6th Feb 20231:44 pmRNSDirector/PDMR Shareholding
18th Jan 20237:00 amRNSThird Quarter Trading Update
16th Jan 20237:00 amRNS£80m contract win with UK MOD
10th Jan 20233:43 pmRNSDirector/PDMR Shareholding
5th Jan 20232:38 pmRNSDirector Declaration
12th Dec 20225:23 pmRNSDirectorate Change
12th Dec 20221:44 pmRNSDirector/PDMR Shareholding
6th Dec 20227:00 amRNSCompletion of the acquisition of Air Affairs
23rd Nov 202212:16 pmRNSCompletion of the acquisition of Avantus
10th Nov 202212:13 pmRNSDirector/PDMR Shareholding
10th Nov 20227:00 amRNSInterim Results
12th Oct 20227:00 amRNSSecond Quarter Trading Update
11th Oct 20223:28 pmRNSDirector/PDMR Shareholding
3rd Oct 20227:06 amRNSAcquisition of Air Affairs & disposal of Space NV
12th Sep 20223:28 pmRNSDirector/PDMR Shareholding
26th Aug 202212:53 pmRNSDirector/PDMR Shareholding
10th Aug 20223:36 pmRNSDirector/PDMR Shareholding
9th Aug 20227:00 amRNSDelivering growth in the US with $45m contract win
5th Aug 20226:22 pmRNSProposed Acquisition of Avantus Federal LLC
1st Aug 20223:19 pmRNSHolding(s) in Company
21st Jul 20223:18 pmRNSResult of AGM
21st Jul 20227:00 amRNSFirst Quarter Trading Update
19th Jul 20225:24 pmRNSHolding(s) in Company
12th Jul 20222:09 pmRNSHolding(s) in Company
12th Jul 20221:47 pmRNSDirector/PDMR Shareholding
29th Jun 20225:09 pmRNSDirector/PDMR Shareholding
27th Jun 202212:35 pmRNSHolding(s) in Company
15th Jun 20229:53 amRNSHolding(s) in Company
13th Jun 202212:59 pmRNSDirector/PDMR Shareholding
13th Jun 202212:28 pmRNSAnnual Financial Report
6th Jun 202210:52 amRNSHolding(s) in Company
30th May 202212:03 pmRNSNotification of Major Shareholding
23rd May 20227:00 amRNSConfirmation of Full Year Results
19th May 20227:00 amRNSPreliminary Results
18th May 20227:00 amRNSDirectorate Change
17th May 202211:24 amRNSHolding(s) in Company
16th May 20221:45 pmRNSHolding(s) in Company
10th May 202211:49 amRNSDirector/PDMR Shareholding
27th Apr 20227:00 amRNSInvestor Seminar: Delivering our global ambition
26th Apr 20221:37 pmRNSHolding(s) in Company
21st Apr 20229:15 amRNSHolding(s) in Company
20th Apr 20227:00 amRNSFourth Quarter Trading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.